![1]()
News
Closed-loop insulin control for T2DM is feasible in hospital setting
July 12, 2018
ORLANDO – Noncritical patients tolerated automated devices and had fewer clinically significant hypoglycemic events.
![1]()
Video
Peer mentorship, groups help combat burnout in female physicians
May 29, 2018
NEW YORK – Female physicians are at higher risk of burnout in part because of lingering implicit and unconscious biases in society and the workplace.
![1]()
Video
VIDEO: Fix physician burnout? You need more than yoga
April 20, 2018
Physicians looking to renew their professional satisfaction and personal well-being should turn to an unlikely ally.
![1]()
Video
VIDEO: Andexanet alfa effectively reverses factor Xa anticoagulant
March 21, 2018
ORLANDO – Now that reversal is possible prescriptions for the already-popular direct Factor Xa inhibitor, anticoagulants should spike higher.
![1]()
Video
Post-ACS death lowered in ODYSSEY Outcomes
March 10, 2018
ORLANDO – Mortality and major adverse cardiovascular events were cut 15%, but that’s not all.
![1]()
Video
VIDEO: New stroke guideline embraces imaging-guided thrombectomy
January 25, 2018
The latest U.S. acute ischemic stroke guideline adopts imaging as the main thrombectomy eligibility criterion out to 24 hours after stroke onset.
![1]()
Video
VIDEO: How to manage surgical pain in opioid addiction treatment
October 25, 2017
NEW ORLEANS – It is possible to give opioid addiction patients opioids for post-op surgical pain without increasing the risk of relapse.
![1]()
Video
VIDEO: What’s new in AAP’s pediatric hypertension guidelines
September 15, 2017
SAN FRANCISCO – Some of the advice is similar to the group’s last effort in 2004, but there are a few key changes.
![1]()
News
VIDEO: Clopidogrel bests ticagrelor in PCI for ACS in real-world study
August 30, 2017
BARCELONA – Fewer adverse events seen with less potent platelet inhibition in contemporary practice in CHANGE DAPT.
![1]()
Video
VIDEO: Rivaroxaban plus aspirin cut cardiovascular events in stable patients
August 28, 2017
BARCELONA – The COMPASS trial produced “unambiguous results that should change guidelines and the management of stable coronary artery disease,” commented Eugene Braunwald, MD.
